Search for: "Bristol Myers Squibb Manufacturing Company" Results 41 - 60 of 161
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Feb 2017, 8:05 am by Law Offices of Jeffrey S. Glassman
For this reason, sales of Eliquis, manufactured by Bristol Myers Squibb, are beginning to approach the numbers of Xarelto sales. [read post]
7 Feb 2017, 11:58 am by Clay Hodges
In 2015, Bristol-Myers Squibb Company paid $18.8 million to physicians relating to the sale and/or promotion of Eliquis. [read post]
19 Jan 2017, 1:07 pm by Amy Howe
Today’s grant comes in Bristol-Myers Squibb Co. v. [read post]
12 Jan 2017, 7:01 am by John Elwood
National Association of Manufacturers v. [read post]
11 Jan 2017, 7:19 am by Kate Howard
National Association of Manufacturers v. [read post]
28 Nov 2016, 3:52 am by jromDLT
Abilify’s History Approved by the FDA in 2002, Abilify, which comes in many forms, including a tablet, liquid or an injection (including an extended-release injection), is manufactured by Bristol-Myers Squibb and the Otsuka America Pharmaceutical, and has consistently topped 5 billion dollars in yearly sales. [read post]
10 Oct 2016, 2:59 pm by Michael Grossman
Made by Bristol-Myers Squibb, Taxol is also used as a component of intravenous chemotherapy. [read post]
16 Sep 2016, 4:07 am by John Collins
Previously, the Full Court in Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2 (BMS) upheld Justice Yates’ ruling at first instance that the grant of an ‘exclusive licence’ meant an exclusive licence to undertake all of the activities within the meaning of “exploit” as defined in the Patents Act. [read post]
7 Sep 2016, 12:29 pm by Jim Higgins
The antipsychotic drug Abilify, also known as aripiprazole, is manufactured by Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. [read post]
7 Sep 2016, 12:29 pm by Jim Higgins
The antipsychotic drug Abilify, also known as aripiprazole, is manufactured by Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. [read post]
30 Aug 2016, 5:45 am by Adam Steinman
From the introduction: Bristol Myers Squibb Company (BMS), a pharmaceutical manufacturer, conducts significant business... [read post]
10 Aug 2016, 5:23 pm by Kevin LaCroix
On August 5, 2016, a shareholder filed a derivative lawsuit in New York (New York County) Supreme Court against Bristol-Myers Squibb, as nominal defendant, and the company’s board of directors. [read post]
10 Aug 2016, 2:40 pm by Michael Grossman
Created by the Japanese company Otsuka Pharmaceutical, it is marketed in North America by Otsuka America and their partner company Bristol Myers-Squibb, an enormous biopharmaceutical manufacturer/marketer. [read post]
21 Apr 2016, 7:35 am by Devika Agarwal
The first application pertained to Bristol-Myers Squibb’s cancer drug, Dastanib, which was filed by Indian generic drug manufacturer, BDR Pharma. [read post]
12 Apr 2016, 10:57 am by Dr. Shezad Malik
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
8 Mar 2016, 8:01 am by Dr. Shezad Malik
Nicholas Meyer recently filed against Bristol-Myers Squibb and Otsuka Pharmaceutical Co. in the U.S. [read post]
10 Nov 2015, 3:41 am by Broc Romanek
Don’t forget to tune in today for the webcast – “How to Draft Meaningful Sustainability Reports” – to hear Lou Coppola of the Governance & Accountability Institute, Kate Kelly of Bristol-Myers Squibb and Pam Styles of Next Level Investor Relations explain the keys to drafting sustainability reports that are meaningful to investors & other constituents and a “how to” list of things you should be aware of when drafting. [read post]